268 related articles for article (PubMed ID: 36476385)
1. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
Ravkin HD; Yom-Tov E; Nesher L
J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
[TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
[TBL] [Abstract][Full Text] [Related]
3. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
[TBL] [Abstract][Full Text] [Related]
4. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
[TBL] [Abstract][Full Text] [Related]
6. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.
Madaniyazi L; Seposo X; Ng CFS; Tobias A; Toizumi M; Moriuchi H; Yoshida LM; Hashizume M
Jpn J Infect Dis; 2022 Mar; 75(2):209-211. PubMed ID: 34470964
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.
Li Y; Wang X; Cong B; Deng S; Feikin DR; Nair H
J Infect Dis; 2022 Mar; 225(6):957-964. PubMed ID: 35030633
[TBL] [Abstract][Full Text] [Related]
8. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
[TBL] [Abstract][Full Text] [Related]
10. Global patterns of rebound to normal RSV dynamics following COVID-19 suppression.
Thindwa D; Li K; Cooper-Wootton D; Zheng Z; Pitzer VE; Weinberger DM
BMC Infect Dis; 2024 Jun; 24(1):635. PubMed ID: 38918718
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.
Bardsley M; Morbey RA; Hughes HE; Beck CR; Watson CH; Zhao H; Ellis J; Smith GE; Elliot AJ
Lancet Infect Dis; 2023 Jan; 23(1):56-66. PubMed ID: 36063828
[TBL] [Abstract][Full Text] [Related]
12. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
Stein RT; Zar HJ
Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
[TBL] [Abstract][Full Text] [Related]
13. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
[TBL] [Abstract][Full Text] [Related]
15. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
[TBL] [Abstract][Full Text] [Related]
16. Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Meslé MMI; Sinnathamby M; Mook P; ; Pebody R; Lakhani A; Zambon M; Popovici O; Lazăr M; Ljubović AD; Vukmir NR; Altaş AB; Avci E; Łuniewska K; Szymański K; Gargasiene G; Muralyte S; Dziugyte A; Zahra G; Gonçalves AR; Spedaliero T; Fournier G; Alvarez-Vaca D; Petrović G; Tabain I; Prosenc K; Socan M; Protic J; Dimitrijevic D; Druc A; Apostol M; Kalasnikova KK; Nikisins S; Reiche J; Cai W; Meijer A; Teirlinck A; Larrauri A; Casas I; Enouf V; Vaux S; Lomholt FK; Trebbien R; Jirincova H; Sebestova H; Rózsa M; Molnár Z; Aspelund G; Baldvinsdottir GE; Cottrell S; Moore C; Kossyvakis A; Mellou K; Sadikova O; Tamm JK; Bossuyt N; Thomas I; Staroňová E; Kudasheva L; Pleshkov B; Ikonen N; Helve O; Dickson E; Curran T; Komissarova K; Stolyarov K; Vysotskaya V; Shmialiova N; Rakočević B; Vujošević D; Abovyan R; Sargsyan S; Zakhashvili K; Machablishvili A; Koshalko O; Demchyshyna I; Mandelboim M; Glatman-Freedman A; Gunson R; Karanwal S; Guiomar R; Rodrigues AP; Bennett C; Domegan L; Kalaveshi A; Jakupi X; Ovliyakulova G; Korsun N; Vladimirova N
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13219. PubMed ID: 38025589
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.
Fung T; Goh J; Chisholm RA
J Theor Biol; 2024 Jun; 587():111817. PubMed ID: 38599566
[TBL] [Abstract][Full Text] [Related]
18. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?
van Summeren J; Meijer A; Aspelund G; Casalegno JS; Erna G; Hoang U; Lina B; ; de Lusignan S; Teirlinck AC; Thors V; Paget J
Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296672
[TBL] [Abstract][Full Text] [Related]
19. The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic.
Alkharsah KR
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363580
[TBL] [Abstract][Full Text] [Related]
20. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic.
Williams TC; Sinha I; Barr IG; Zambon M
Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
